Iron Deficiency Anemia: Global Burden, Pathophysiology, and WHO Statistics

Pathophysiology

Iron deficiency anemia (IDA) results from insufficient iron for hemoglobin synthesis. Iron is essential for heme production; without it, erythropoiesis produces microcytic, hypochromic RBCs with reduced O₂-carrying capacity.

Global Epidemiology (WHO Estimates)

  • Total anemia: ~1.8 billion people (2019).
  • IDA contribution: ~50% of anemia cases (~900 million).
  • High-risk groups:
    • Pregnant women: 37% (range 20–80% by region).
    • Children 6–59 months: 40% (42% in some estimates).
    • Women of reproductive age: 30%.
  • Regional variation: Highest in sub-Saharan Africa, South Asia; driven by dietary iron bioavailability, infectious diseases (malaria, hookworm), and maternal/child health access.

Causes

  • Increased demand: Growth (infants, adolescents), pregnancy, lactation.
  • Decreased intake/absorption: Low heme iron diet (vegan/vegetarian without planning), phytates/polyphenols inhibiting absorption, gastric bypass, H. pylori, celiac disease, atrophic gastritis.
  • Blood loss: Menstruation, GI bleeding (ulcers, neoplasms, NSAIDs), hookworm, frequent blood donation.

Diagnosis

  • CBC: Microcytic (low MCV), hypochromic (low MCHC), high RDW.
  • Iron studies: Low ferritin (<15–30 ng/mL) = specific; low serum iron, high TIBS, low transferrin saturation (<16%).
  • sTfR (soluble transferrin receptor): Elevated in IDA; helps differentiate from anemia of chronic disease.

Treatment

  • Oral iron (ferrous sulfate 325 mg = 65 mg elemental Fe daily/twice daily; newer alternate-day dosing improves absorption).
  • IV iron (ferric carboxymaltose, iron sucrose, ferumoxytol) for intolerance, malabsorption, severe IDA, pregnancy 2nd/3rd trimester, active IBD.
  • Address underlying cause (GI eval for occult bleeding, menstrual management, dietary counseling).

Prevention: Iron-fortified foods, delayed cord clamping, antenatal supplementation, deworming, dietary diversity.

Blood Disorders - Related Articles